PECCI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 5.694
AS - Asia 4.606
EU - Europa 4.068
SA - Sud America 595
AF - Africa 81
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.064
Nazione #
US - Stati Uniti d'America 5.549
CN - Cina 2.559
IE - Irlanda 981
SG - Singapore 942
HK - Hong Kong 566
IT - Italia 508
FI - Finlandia 502
DE - Germania 493
BR - Brasile 490
RU - Federazione Russa 436
UA - Ucraina 398
SE - Svezia 259
GB - Regno Unito 204
VN - Vietnam 195
CA - Canada 82
IN - India 73
FR - Francia 70
TR - Turchia 47
NL - Olanda 43
AR - Argentina 42
BD - Bangladesh 38
JP - Giappone 38
MX - Messico 33
BE - Belgio 28
IQ - Iraq 27
ES - Italia 23
ZA - Sudafrica 22
EC - Ecuador 19
ID - Indonesia 19
PL - Polonia 18
MA - Marocco 16
RO - Romania 16
AT - Austria 15
CZ - Repubblica Ceca 15
CH - Svizzera 14
PK - Pakistan 11
IR - Iran 10
PY - Paraguay 10
KR - Corea 9
TN - Tunisia 9
AZ - Azerbaigian 8
MU - Mauritius 8
PA - Panama 8
TH - Thailandia 8
AU - Australia 7
BO - Bolivia 7
CO - Colombia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
DZ - Algeria 6
EG - Egitto 6
KE - Kenya 6
NZ - Nuova Zelanda 6
RS - Serbia 6
UZ - Uzbekistan 6
CR - Costa Rica 5
JM - Giamaica 5
EU - Europa 4
GR - Grecia 4
HU - Ungheria 4
JO - Giordania 4
KG - Kirghizistan 4
LT - Lituania 4
PT - Portogallo 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IL - Israele 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
PH - Filippine 3
BH - Bahrain 2
DM - Dominica 2
EE - Estonia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MK - Macedonia 2
NI - Nicaragua 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
Totale 15.049
Città #
Dublin 977
Chandler 833
Jacksonville 570
Hong Kong 566
Dallas 563
Nanjing 555
Ashburn 437
Beijing 429
Singapore 417
Boardman 272
Nanchang 217
Munich 208
Princeton 197
Wilmington 197
Lawrence 180
Changsha 177
Medford 163
Shenyang 159
Hebei 155
Helsinki 146
Los Angeles 145
Jiaxing 127
Milan 112
Ann Arbor 102
New York 94
Tianjin 92
Pavia 91
Ho Chi Minh City 82
Buffalo 80
Hangzhou 76
Moscow 75
Shanghai 75
Turku 66
Redondo Beach 64
Woodbridge 53
São Paulo 51
Hanoi 42
Houston 41
Verona 33
Tokyo 32
Norwalk 31
Guangzhou 29
Seattle 27
The Dalles 27
Montreal 25
Brooklyn 24
Brussels 24
Denver 24
London 24
Toronto 24
Ankara 23
Fairfield 23
Chicago 22
Phoenix 21
Nuremberg 20
Pune 20
Zhengzhou 20
Chennai 19
Orem 19
Columbus 18
Council Bluffs 18
Falkenstein 17
Auburn Hills 16
Falls Church 16
Mexico City 16
Ningbo 16
Santa Clara 16
Atlanta 15
Johannesburg 15
San Francisco 15
San Jose 15
Stockholm 15
Warsaw 15
Boston 14
Brasília 14
Jinan 14
Frankfurt am Main 13
Rome 13
Secaucus 13
Manchester 12
Rio de Janeiro 12
Taizhou 12
Curitiba 11
Timisoara 11
Amsterdam 10
Belo Horizonte 10
Biên Hòa 10
Des Moines 10
St Petersburg 10
Baghdad 9
Fuzhou 9
Paris 9
Zurich 9
Baku 8
Bangkok 8
Brno 8
Mumbai 8
Panama City 8
Vancouver 8
Chongqing 7
Totale 9.900
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 274
Anemia in patients with Covid-19: pathogenesis and clinical significance 255
MYH9-Related Disorders. 223
A qualitative and quantitative cytochemical assay of dihydrofolate reductase in megakariocytes of patients with 5q-syndrome. 144
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 141
A case of phagocytic multiple myeloma 134
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 130
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 128
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 127
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 126
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 126
Cochlear implantation is safe and effective in patients with MYH9-related disease. 125
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 123
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 122
5′UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia 119
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 117
Endogenous fibronectin modulates collagen-dependent spreading and proplatelet formation by human megakaryocytes 114
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 114
Dihydrofolate reductase activity in the erythroblasts of patients with 5q-syndrome. 111
A case of metastatic malignant melanoma with bone marrow involvement. 111
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 111
Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle. 111
Chaperone molecules concentrate together with the ubiquitin–proteasome system inside particulate cytoplasmic structures: possible role in metabolism of misfolded proteins 110
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 109
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 108
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 106
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 106
Spectrum of the mutations in Bernard-Soulier syndrome. 105
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 105
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis. 105
Bone marrow necrosis in acute lymphoblastic leukemia. 104
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 103
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 102
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 101
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 101
3D silk bone marrow model: a promising tool to test efficacy of new biomimetic drugs on platelet production 101
A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia. 100
Inherited thrombocytopenias. The evolving spectrum. 100
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 100
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 98
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 98
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 97
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 97
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 95
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 95
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. 94
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 94
A novel mutation in gp1bb reveals the role of the cytoplasmic domain of gpibβ in the pathophysiology of bernard‐soulier syndrome and gpib‐ix complex assembly 93
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 92
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 90
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 90
The Case. Proteinuria and low platelet count. 89
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 89
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 88
Lessons in platelet production from inherited thrombocytopenias. 87
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. 87
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 87
Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome. 86
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia 85
R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17. 84
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 84
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. 83
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 83
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. 82
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. 82
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 82
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 81
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel GFI1B germline mutation 81
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. 80
The D1424N and R1933X mutations of MYH9 result in an altered proplatelet formation by human megakaryocytes 79
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 79
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 78
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 78
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 78
Severe to profound deafness may be associated with MYH9-related disease: Report of 4 patients 78
ANKRD26-related thrombocytopenia and myeloid malignancies 78
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 77
Expression, activation, and subcellular localization of the Rap1 GTPase in cord blood-derived human megakaryocytes. 77
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 77
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes. 77
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 77
Expression of dipeptidylaminopeptidase IV/CD26 in peripheral blood lymphocytes of hemophilic subjects. 77
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 77
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim 77
Expression, activation and subcellular localization of the Rap1 GTPase in human cord blood-derived megakaryocytes 76
International prognostic scoring system (IPSS) and other prognostic systems for myelodysplastic syndromes (MDS). 76
Cord blood in vitro expanded CD41+ cells: Identification novel components of megakaryocytopoiesis 76
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia 76
Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow. 75
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 75
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 75
Mutations Identified in Thrombocytopenia THC2 Are Likely to Dysregulate ANKRD26 Expression. 75
Low-dose thalidomide ameliorates cytopenia and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II clinical trial. 74
Peripheral arteriopathy of the lower limbs in a patient with severe congenital thrombocytopenia. 74
Von Willebrand Factor and GPIb regulates proplatelets formation by human megakaryocytes. 73
Cutaneous involvement by post-polycythemia vera myelofibrosis. 73
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia 73
Gene expression profiling of megakaryocytes from human cord blood. 73
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 73
Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule. 72
Totale 9.858
Categoria #
all - tutte 70.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021611 0 0 0 0 0 100 6 145 87 126 116 31
2021/2022866 15 1 21 14 38 29 26 47 49 39 122 465
2022/20232.484 265 165 14 215 237 250 2 125 1.097 12 67 35
2023/20241.020 96 166 25 81 161 237 55 54 8 50 45 42
2024/20252.960 70 235 77 96 68 197 201 238 643 100 341 694
2025/20263.691 498 470 882 841 747 253 0 0 0 0 0 0
Totale 15.545